Hempalta (CVE:HEMP) Shares Up 33.3% – Still a Buy?

Hempalta Corp. (CVE:HEMP – Get Free Report)’s stock price shot up 33.3% on Friday . The company traded as high as C$0.07 and last traded at C$0.06. 182,500 shares traded hands during mid-day trading, an increase of 77% from the average session volume of 103,117 shares. The stock had previously closed at C$0.05. Hempalta Price [...]

featured-image

Hempalta Corp. ( CVE:HEMP – Get Free Report )’s stock price shot up 33.3% on Friday .

The company traded as high as C$0.07 and last traded at C$0.06.



182,500 shares traded hands during mid-day trading, an increase of 77% from the average session volume of 103,117 shares. The stock had previously closed at C$0.05.

Hempalta Price Performance The business’s 50 day moving average price is C$0.05 and its 200 day moving average price is C$0.09.

The stock has a market capitalization of C$5.70 million, a P/E ratio of -0.48 and a beta of -0.

10. The company has a debt-to-equity ratio of 28.72, a current ratio of 3.

99 and a quick ratio of 0.88. Insider Activity at Hempalta In other news, Director Darren Hartley Bondar sold 453,000 shares of the company’s stock in a transaction dated Monday, January 6th.

The shares were sold at an average price of C$0.06, for a total transaction of C$26,274.00.

In the last ninety days, insiders purchased 610,474 shares of company stock worth $27,499. 27.90% of the stock is owned by company insiders.

About Hempalta Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products.

The company also engages in the hemp carbon credit market. Recommended Stories Five stocks we like better than Hempalta What Do S&P 500 Stocks Tell Investors About the Market? Bloom Energy: Powering the Future With Decentralized Energy What is a Bond Market Holiday? How to Invest and Trade Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul Insider Selling Explained: Can it Inform Your Investing Choices? Why Traders Are Buying the Dip on Johnson & Johnson Stock Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter .

.